Participants are not assigned an intervention as a part of the study
OtherParticipants are not assigned an intervention as a part of the study
NCT Number: NCT06738069
Screening of Chronic Kidney Disease among pregnant women for early detection
Trial opening soon.
Get NotifiedNormal pregnancy associated with plasma volume expansion and hormonal changes lead to an increase in GFR of 40% to 65% in first and second trimester , with decrease in GFR of approximately 15% to 20% in the third trimester . Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function, present for a minimum of 3 months, with significant health implications .CKD classification is based on Cause, GFR category (G1-G5), and Albuminuria category (A1-A3), abbreviated as CGA . CKD during pregnancy is a major health concern ,affecting up to 3% of women of reproductive age in high-income countries, but estimated prevalence may be as much as 50% higher in low and middle-income countries (LMICs). Pregnant women with CKD at high risk of adverse maternal and fetal outcome , including hypertension development or worsening ,Preeclampsia, eclampsia , Anemia , platelets abnormalities , worsening kidney function ,need for cesarean section ,Pregnancy loss ,stillbirth ,Preterm labor ,Intrauterine growth restriction . CKD if detected and treated early in its course, ESRD is often preventable, especially for high risk individuals. CKD is often unrecognizable and asymptomatic until it is in its later stages, when the chances of preventing kidney failure are limited. Therefore, in order to administer targeted therapeutic interventions . early identification and stratification of those at highest risk of CKD are urgently needed. Screening programs using state of the art point-of-care testing equipment with blood and urine samples can test for CKD both quickly and accurately
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants are not assigned an intervention as a part of the study
Time frame: Through study completion, an average of 3 years
Time frame: Through study completion, an average of 3 years
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Frequency of Chronic Kidney Disease Among Pregnant Women at Assuit University Hospitals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06712719
CKD
Indianapolis, Indiana, United States
View Trial DetailsNCT07268807
Anemia, CKD
Nanjing, Jiangsu, China
View Trial DetailsNCT07141628
CKD, Cardiovascular Diseases
Nîmes, France
View Trial DetailsNCT07107087
Body Weight, Body Weight Changes
View Trial Details